Prinoxodan
Product Specifications
UNSPSC Description
Prinoxodan (RGW2938) is a phosphodiesterase inhibitor.
Target Antigen
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/RGW2938.html
Purity
99.83
Solubility
Ethanol : < 1 mg/mL (ultrasonic;warming;heat to 60°C)
Smiles
O=C1NC2=C(C=C(C3=N[N]C(CC3)=O)C=C2)CN1C
Molecular Weight
257.27
References & Citations
[1]Artigou JY, et al. [Evaluation of a new cardiotonic agent on human isolated atrium]. Ann Cardiol Angeiol (Paris). 1993 Feb;42(2):79-82.|[2]Barrett JA, et al. Pharmacology of RG W-2938: a cardiotonic agent with vasodilator activity. J Cardiovasc Pharmacol. 1990 Oct;16(4):537-45.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-U00208/Prinoxodan-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-U00208/Prinoxodan-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
111786-07-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
